Moderna is establishing manufacturing footholds in far-flung outposts including Australia, Kenya, Canada and the U.K. Now, the company is setting up a plant closer to home in Massachusetts. The ...

British-based researchers are hoping to reduce the costs of mRNA production by expanding the range of manufacturing techniques. A team has created and are testing a huge library of RNA-polymerases, ...

TriLink BioTechnologies, a unit of Maravai LifeSciences, said it plans to expand its mRNA manufacturing operations to meet growing demand from late-stage drug developers. The new 32,000-square-foot ...

The "mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA ...

Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "mRNA Synthesis and Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Application Area, Therapeutic Area and Key ...

EPS of $7.00 beats by $3.57 BioNTech’s Singapore mRNA manufacturing facility will create regional manufacturing capacities in support of BioNTech’s growing pipeline of mRNA-based vaccines and ...

Sensible Biotechnologies aims to build a cell-based platform for cost-efficient and scalable manufacturing of high-quality mRNA. Proceeds will be used to optimize and scale Sensible's mRNA ...

The importance of in vitro transcription as a component of the mRNA therapeutic manufacturing workflow has grown significantly in recent years. The in-process raw materials for synthetic mRNA ...

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and ...

CAMBRIDGE, MA -- A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U ...

- Platform Enables Customers to Manufacture mRNA with Substantial Reduction in dsRNA and Manufacturing Complexities; Integrable into Current mRNA Workflows - - Platform Currently Available Under Early ...